Consequences of Weight Cycling: An Increase in Disease Risk?
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ABSTRACT
Int J Exerc Sci 2(3) :191 -201, 2009. Research indicates that weight cycling, or “yo-yo dieting” is a
common occurrence in overweight and obese populations. The long term negative health
consequences of weight cycling are debated and it is unclear whether or not this weight change
pattern poses a greater disease risk compared to obesity maintenance. This review discusses the
prevalence of weight cycling and physiological alterations occurring during weight loss that
promotes weight regain. We also discuss the effect weight regain has upon adipose tissue in
terms of rate and type of accumulation. Also within this review are discussions surrounding the
previously published literature based upon human and rodent research. We focus on previous
limitations and difference in experimental design that have perhaps resulted in mixed findings
concerning independent effects of weight cycling on health parameters. The final purpose of this
review is to discuss future directions in evaluating the pro-inflammatory response to weight
cycling in order to compare the disease risk compared to obesity maintenance.
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Overview of the Problem
As obesity is becoming increasingly more
prevalent in the United States, weight loss
to reduce adipose tissue mass is strongly
promoted as a means to decrease the
disease risk associated with excess
adiposity (5, 57).
Unfortunately, the
majority of individuals who lose weight are
unlikely to maintain the reduced weight for
an extended period of time (15, 51, 59).
Repeated periods of weight loss and regain
form a pattern known as weight cycling.
Hill (2004) indicates that popular and lay
literature have asserted that weight cycling

(i.e. “yo-yo dieting”) may increase the risk
of developing cardiovascular disease or
type II diabetes to a greater extent than
remaining weight stable at an obese Body
Mass Index (BMI; ≥30 kg/m2)(27). The
scientific literature is inconsistent regarding
the long-term consequences of weight
cycling. Because there is no universallyaccepted definition of weight cycling,
differences in experimental design may
have contributed to discrepancies in
scientific outcomes.
Weight gain has significant implications
concerning disease risk, which is believed
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(43). Researchers believe this is due to the
energy gap created during caloric
restriction
where
decreased
energy
expenditure is paired with an increased
drive to eat (43). Rodent studies have
demonstrated that this gap persists
regardless of the duration of weight
reduction, which increases the probability
of weight regain.(41). This drive to eat
causes a hyperphagic response when free
access to food is allowed and when paired
with suppressed lipid utilization, weight
regain is often rapid and efficient (41, 43).
While this finding was elucidated through
use of a rodent model, human weight
regain data supports this concept. One year
after a modest weight loss (14.5% of body
weight), Votruba et al. (2002) reported that
within a year of weight loss, 16 out of 28
women regained weight and had a 19%
increase in body weight and a 26% increase
in percent fat mass (59). Weiss reported
that by one year after a modest weight loss
(10% of body weight), 33% of adult subjects
regained all lost weight. Furthermore, they
concluded that the odds of regaining were
positively associated with the percentage of
initial weight lost (63). Field et al. reported
that approximately 55% of overweight and
obese women who lost 10% of their body
weight regained all lost weight within 4
years (15). In support of this finding,
within 9 years of the initial weight loss (5%
of body weight), 95% of women and 93% of
men were unable to maintain the reduced
body weight(51). Collectively, these studies
suggest that while initial weight loss is
possible,
long-term
maintenance
is
problematic, especially when large amounts
of weight are lost or an individual is
overweight or obese.

to be mediated by an elevated level of
systemic
inflammation.
Low-grade
systemic inflammation is associated with
obesity and it may serve as a link between
adiposity and the development of
cardiovascular disease and type 2 diabetes
(66). To our knowledge, the proinflammatory effects of weight cycling have
not been examined. Discerning a difference
in disease risk between maintenance of
obesity and weight cycling is important and
may provide insight concerning individual
differences in disease progression.
If
weight cycling is associated with an
increased
disease
risk,
continually
recommending weight loss to those unable
to maintain reduced weights may be a
major public health issue. This review has
two aims: 1) to compare studies that both
support or refute the theory that weight
cycling is independently associated with
increases in disease risk2) to discuss the
possibility that weight cycling impacts proinflammatory biomarkers.
Weight Cycling: A Disruption of Body
Weight Maintenance?
It has been estimated 24% of American men
and 38% of women are currently
attempting to lose weight (35, 53, 64).
When individuals with an obese BMI are
considered, 65% of men and 68% of women
are trying to lose weight, which is a fivefold increase compared to those within the
normal BMI (18-24.9 kg/m2) range that are
trying to lose weight (64). While successful
weight loss is achieved, researchers have
indicated that long-term maintenance of a
reduced weight appears to be rare.
The probability of weight regain increases
in the time following initial weight loss
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Repeated bouts of weight loss followed by
regain forms a pattern known as weight
cycling.
Survey data collected by
Williamson and colleagues (64) indicated
that 25% of men and 27% of women trying
to lose weight have made long-term
attempts (classified as trying for over 1 year
or “always trying to lose weight”). It has
also been shown that 7% of men and 10% of
women can be classified as severe weight
cyclers (intentionally lost at least 5 kg and
regained at least three different times),
while 11% of men and 19% of women are
mild weight cyclers (lost and regained at
least 5 kg on one or two occasions) (36).
While these results were generated from a
group of adults in Finland, the conclusion
that 18% of men and 27% of women weight
cycle is comparable to the prevalence
described by Williamson et al. (64). These
numbers are likely a conservative estimate
of the prevalence of weight cycling, which
may be even greater in the United States.

(favoring carbohydrate oxidation) may
significantly affect the propensity to regain
weight (43). For instance, in the 16 weeks
following moderate weight loss (14%), food
efficiency was increased 10-fold upon the
first day of a 56-day re-feeding in weight
cycle rats compared to rats with established
obesity.
While this dramatic rise was
reduced within several days, food
efficiency remained elevated above levels in
obese mice for the first 4 weeks of relapse
(41). The most dramatic changes occurred
during the first week of relapse, a time
when nearly 40% of lost weight, which was
primarily fat mass, was regained (41, 42).
Researchers also noted that as the length of
maintenance increased, the amount of
weight regained upon relapse also
increased.
Furthermore, regain was
accompanied by a 30% increase in
adipocyte concentration per fat pad.
Based on the above literature, it is clear that
weight gain during relapse appears to
induce more rapid adipose tissue growth
and hyperplasia due to metabolic shifts
favoring lipid storage. Because adipose
tissue is a metabolically active tissue,
responsible for production of leptin,
cytokines and adiponectin as well as
responding
to
traditional
hormone
systems(32), it is possible that the
consequences of weight gain during relapse
may also differ from that of initial weight
gain. In recent years, lay literature has
asserted that weight cycling may be more
detrimental to health than simply
remaining overweight or obese (27, 30).
Researchers have found associations
between weight cycling and an overshoot
of lipogenic enzyme, triglyceride and
cholesterol levels in animals and increased
risk of heart attack and stroke in humans (4,

Does Weight Regain Disrupt Normal
Physiology?
The physiological changes associated with
weight cycling, such as energy expenditure,
metabolism and fuel utilization, have been
documented using a rat model. MacLean
and colleagues (2004) have documented the
physiological alterations occurring in
obesity-prone rats that contribute to the
rapid, efficient regain during relapse
following weight loss and maintenance.
Their focus has been on the energy gap
created during a period of caloric restriction
that is characterized by decreased energy
expenditure and an increased drive to eat
(42).
They found that in addition to
changes in energy intake, alterations in
metabolic efficiency and fuel utilization
International Journal of Exercise Science
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16, 34, 52). However, other researchers
noted no long term adverse effects on body
composition, blood pressure, lipid profile
or risk of developing type II diabetes (13,
22, 37, 49, 56). Due to limited research in the
area of weight cycling all of the negative
consequences may not be known. Existing
studies differ considerably in their research
design, subject population used, duration of
treatment, incorporation of exercise,
magnitude and frequency of weight cycles.
The lack of a universal definition of weight
cycling is perhaps a great contributor to the
variability within experimental design.
This variability is discussed in greater detail
in the following sections.

likely explanation for inconsistent findings
is due to the manner in which the weight
cycling response is elicited.
In agreement with the series of studies
completed by MacLean et al., rapid regain
occurs during relapse in rats that have been
on caloric restriction diets (6, 17, 26, 28).
Weight cycling was associated with
increased food efficiency (6, 50) and
increased caloric consumption (26, 52).
Reed et al. found that despite being at lower
weights than control rats, weight cycled
rats were significantly fatter(50). Ilagan et
al. reported that weight cycled rats had a
lower percentage of fat free mass than their
free fed (high fat diet) counterparts and that
amount of weight lost during period of
restriction decreased with each successive
cycle (28). During re-feeding periods in
weight cycled rats, researchers have
consistently
reported
overshoots
in
lipoprotein lipase, serum triglycerides, and
serum cholesterol above what has been
observed in rats that are free-fed a high fat
diet (17, 34, 52). It has been speculated that
body weight overshoot may create a state of
hyperlipogenesis that may persist for
several days after re-feeding. Kim et al.
demonstrated that fasting serum leptin was
significantly increased in weight cycled rats
compared to lean and pair-fed controls
despite similar quantities of fat mass(33).
Since leptin concentration is highly
correlated to the degree of adiposity (11,
39), further interpretation of this finding
suggests that weight cycling may induce a
physiological change in adipocyte release of
leptin.

According to published research, weight
cycling has been evaluated in one of two
main ways: using a cross-sectional survey
model in humans or a longitudinal
endpoint model in rodents. The next two
sections highlight research that either
support or refute the theory that weight
cycling contributes to detriments in health,
demonstrating the no definite conclusions
can be reached at this time.
Longitudinal Endpoint Analysis of
Weight Cycling: Rodent Models
Utilization of animal experimental models
allows for more control of subject treatment
than a human experimental model. Such
designs
are
useful
for
examining
mechanisms underlying weight cycling;
however, care should be taken when
translating these findings to humans. An
increase in internal validity, resulting from
more control of subject treatments may
explain
why
reported
conclusions
regarding weight cycling in animals is a bit
more consistent than humans. The most
International Journal of Exercise Science
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alterations in body composition, but this
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cycle) have differing effects as suggested by
weight cycling studies in humans.

design that only allowed weight cycled rats
to regain weight until they matched their
obese controls, even though weight gain
was still persisting at that time (6). Also,
Cleary et al. indicated that weight loss and
weight regain were linear in nature,
opposing the “energy gap” theory
proposed by MacLean et al. that contributes
to rapid and efficient regain (9, 10).
However, rats in the Cleary model were fed
a purified diet rather than a high fat diet;
the purified diet contained 20.5% high
nitrogen casein, 50% cornstarch, 5% sucrose
and 5% corn oil with 9% celufil as a filler
(9). Sea et al. demonstrated that re-feeding
rats a moderate fat (22%) diet yielded
blunted responses compared to those fed a
high fat (45%) diet (52). Furthermore, given
a choice, weight cycled rats have been
shown to self-select diets with high fat
content during re-feeding(50), so perhaps a
purified diet was not an appropriate
variable for re-creating the weight cycling
experience. Gray et al. stated that the rate
of each weight loss was not hindered by
weight cycling(23); however, in this study,
the first restriction was marked by a 50%
reduction of intake and the second
restriction was a 75% reduction, so perhaps
weight loss would not have been similar
between weight cycles had the second
restriction not have been so severe. Kim et
al.(33) were not able to demonstrate a
hyperphagic response, but their use of a
24hr fast plus 24hr relapse for 21 cycles may
not have been a design that could show
effects of weight cycling seen in previously
mentioned
studies;
every-other-day
restriction has lead to other positive
adaptations (less weight gain, increased
insulin sensitivity) elsewhere (1). This may
indicate that larger weight cycles (increased
weight loss frequency / magnitude per
International Journal of Exercise Science

Cross-sectional Evaluation of Weight
Cycling: Human Models
Some existing scientific literature supports
the theory that weight cycling increases
disease risk (directly or indirectly) in
humans. Wallner and colleagues found
that a history of weight cycling was
associated with a more pronounced
android fat distribution in women
compared to those who were normalweight or overweight without a history of
weight cycling (60). It is possible that
women who are prone to the accumulation
of abdominal adiposity may be more likely
to weight cycle for a more aesthetically
desirable figure (48). Regardless of whether
weight cycling causes the accumulation of
android adiposity or vice versa, other
researchers have found that a history of
weight
cycling
was
independently
associated with an increased risk of
developing hypertension (24) and clinically
significant decreases in HDL-cholesterol in
women (47). French et al(16) and Vergnaud
et
al.(58)
demonstrated
associations
between weight cycling and risk for heart
attack and stroke, as well as the
development of metabolic syndrome(16,
58). Blair et al. studied men enrolled in the
Multiple Risk Factor Intervention Trial who
were at elevated risk for coronary heart
disease due to smoking, hypertension and
hypercholesterolemia, finding that greater
weight variability over 4 years of follow up
was associated to increase all-cause
mortality(4).
In contrast to the preceding reports, several
other researchers reported that weight
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longitudinal in nature, perhaps the use of
regular exercise as part of the program
acted as a confounding factor, as aerobic
exercise is independently and positively
correlated with decreases in blood pressure
and cholesterol (19, 25).

cycling has no independent impact on
health status. Prentice et al. found that
weight cycling did not significantly alter
body composition (49). However, unlike
Wallner et al.(60), who asked for 4 years
worth of weight history, this study was
completed in only 18 weeks. It may be
possible that any deleterious effects of
weight
cycling
do
not
manifest
immediately or that the magnitude of the
weight loss was not sufficient to induce
long-term change. Li et al. studied obese
patients, in a multi-disciplinary weight loss
program, who had relapsed and re-entered.
Multiple attempts at weight loss over 12
years showed no effect on the rate at which
weight could be lost each time or on blood
pressure or lipid profile; in fact, these
measurements
at
baseline
were
significantly lower at the time of re-entry
compared to the initial start for men and
women (37). Initial blood pressure in men
(134/88 mmHg) and women (126/82
mmHg) was recorded at the restart baseline
at 129/85 mmHg and 121/78 mmHg,
respectively.
While no subjects were
hypertensive, all values remained within
the pre-hypertensive range. Furthermore,
BP has been documented to fluctuate
throughout the day (29). Triglyceride levels
in men and women were reduced by 0.1
and 0.2 mmol/L between initial and restart
baselines and cholesterol was reduced by
0.1 and 0.5 mmol/L, respectively. Women’s
values were all within the normal/low risk
range and men’s values remained in the
borderline high range. Cholesterol values
for both genders were all in the borderline
high risk range. While deemed statistically
significant,
the
differences
between
baselines may not be physiologically
relevant as disease risk did not appear to
change. Even though this study was
International Journal of Exercise Science

A similar exercise effect was reported by
Field et al. where mild and severe weight
cycling was strongly associated with weight
gain and hypertension, controlling the
statistical analysis for weight and weight
gain greatly attenuated this correlation(13);
however, the questionnaire data also
revealed that severe weight cyclers
exercised significantly more that non
weight cyclers. Graci et al. (2004) noted that
weight cycling had no effect on
cardiovascular disease risk factors; weight
cycling throughout adulthood was not
associated
with
changes
in
body
composition, fat distribution blood pressure
or insulin levels(22). One major difference
in this study, compared to those with
competing findings, was that Graci et al.(22)
used morbidly obese subjects (BMI up to 69
kg/m2) and perhaps there is a lesspronounced response to weight cycling in
this population because the subjects already
have an elevated disease risk. Similar
results by Wing et al. (65) and Jeffery et
al.(31) may have been effected by the short
duration of measurement period (2.5 years)
or the failure to use appropriate blood
pressure cuffs for obese patients(24). Field
et al. concluded that 4 years of weight
cycling, prior to diagnosis of type 2
diabetes, was not predictive of disease
development while Wannamethee et al
found that weight fluctuation does not
directly increase risk of death (14, 61).

196

http://www.intjexersci.com

WEIGHT CYCLING AND INCREASED DISEASE RISK
Role of Inflammation in Disease
Progression: Implications for Weight
Cycling

Leptin aids in the transmigration of blood
monocytes
into
adipose
tissue
compartments, where they mature into
macrophages (12). Also, leptin stimulates
pre-adipocyte stem cells to mature into
adipocytes or macrophages.
Thus, an
adiposity driven increase in adipose tissue
macrophages concentration is a result of
monocyte influx and directed pre-adipocyte
transformation (7). Evidence exists that
macrophages may be retained longer in
adipose tissue from obese compared to lean
subjects (40).
In lean individuals, the
actions of leptin and granulocyte
macrophage – colony stimulating factor
(GM-CSF) are opposed by ghrelin;
however, reduced ghrelin in obese
individuals
causes
deregulation
of
macrophage development in adipose tissue
(20).
Macrophage
accumulation
has
significant implications for inflammatory
disease risk because they are a significant
source of IL-6, TNF-α, and IL-8 (62, 67).

When differences in experimental design
are accounted for, a significant gap in
scientific knowledge exists concerning the
exact role of weight cycling in the
progression of chronic diseases that are
normally attributed to excess adiposity. IL6 stimulates hepatic release of acute phase
proteins, including C-Reactive Protein
(CRP) (3, 66). Free fatty acids and TNF- α
act in concert to exacerbate systemic
inflammation (54). IL-8, released from
adipocytes, monocytes and macrophages,
has been thought to induce chemotaxis
helping to form atherosclerotic plaques(21).
IL-6 and TNF-α can act in an autocrine or
paracrine manner, impairing insulin
receptor activity and glucose sensitivity in
adipocytes and muscle tissue (2, 3, 45, 66).
IL-6 and CRP in circulation target and
damage arterial endothelial lining; this
damage helps to initiate or progress
atherosclerosis (3, 46, 66). An increase in
systemic inflammation increases the risk of
developing a variety of diseases.

To our knowledge, there is only one
published study that examined the effect
weight variability has on pro-inflammatory
or related factors. Yatsuya et al. reported
that Japanese men with a history of weight
variability had an independently increased
odds ratio of elevated CRP (68). One
limitation of this study was that it was a
cross-sectional design thus it was not
possible to evaluate cause and effect, no
information on intentionality of weight
change and the cross-sectional design with
a majority of subjects having final BMIs less
than 25 kg/m2.
This lack of literature
suggests that in order to fully understand
the possible effects of weight cycling, we
must include examination of proinflammatory responses to this pattern.

Several mechanisms are responsible for the
pro-inflammatory response in adipose
tissue due to hypertrophy.
Cytotoxic
stressors, such as oxidative stress and
hypoxia, induced by hypertrophy in
adipose tissue have been reported to trigger
subsequent pro-inflammatory events (18,
55). As cellular stress persists, adipocytes
secrete IL-6, TNF-α and leptin (38, 55) and
unless revascularization is adequate, cells
may become necrotic (44). The level of
necrotic adipocyte death is positively
correlated with increased adiposity and
concentration of resident macrophages (8).
International Journal of Exercise Science
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Summary

Hainque B. Adipose tissue IL-6 content correlates
with resistance to insulin activation of glucose
uptake both in vivo and in vitro. J Clin Endocrinol
Metab 87: 2084-2089, 2002.

In recent years, lay and popular literature
has claimed that weight cycling may be
more detrimental that simply remaining
overweight or obese. Scientific research has
yielded mixed results, but this may be due
to differences in population used,
experimental design and method of weight
cycling. A current gap in research is the
pro-inflammatory effect of weight cycling. .
Since obesity is so prevalent, weight loss is
almost universally recommended as
treatment to reduce disease risk.
But
because research indicated that relapse is
likely, it is important to understand if
weight cycling adds to the current disease
risk of obesity. Because weight cycling has
a distinct effect on adipose tissue and
adipose tissue is a source of inflammatory
cytokines, elucidating any increases in
inflammation beyond that measured in
sustained obesity may help us to
understand the independent disease risk
that can be associated with weight cycling.
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